Research ArticleArticle
A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis
Michael A. Benneyworth, Zixiu Xiang, Randy L. Smith, Efrain E. Garcia, P. Jeffrey Conn and Elaine Sanders-Bush
Molecular Pharmacology August 2007, 72 (2) 477-484; DOI: https://doi.org/10.1124/mol.107.035170
Michael A. Benneyworth
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
Zixiu Xiang
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
Randy L. Smith
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
Efrain E. Garcia
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
P. Jeffrey Conn
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
Elaine Sanders-Bush
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis
Michael A. Benneyworth, Zixiu Xiang, Randy L. Smith, Efrain E. Garcia, P. Jeffrey Conn and Elaine Sanders-Bush
Molecular Pharmacology August 1, 2007, 72 (2) 477-484; DOI: https://doi.org/10.1124/mol.107.035170
Research ArticleArticle
A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis
Michael A. Benneyworth, Zixiu Xiang, Randy L. Smith, Efrain E. Garcia, P. Jeffrey Conn and Elaine Sanders-Bush
Molecular Pharmacology August 1, 2007, 72 (2) 477-484; DOI: https://doi.org/10.1124/mol.107.035170
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement